[101] For both of the principal TAVI device companies (Edwards Lifesciences and Medtronic CoreValve), such discussions remain mandatory for provision of a prosthesis for a particular patient from ...
I'm with Dr. David Holmes, a professor of medicine at Mayo Clinic, and we're here to talk about cardiogenic shock. Which approach is the better revascularization strategy in these patients?